Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.

Pathological accumulation of microtubule associated protein tau in neurons is a major neuropathological hallmark of Alzheimer's disease (AD) and related tauopathies. Several attempts have been made to promote clearance of pathological tau (p-Tau) from neurons. Transcription factor EB (TFEB) has...

Full description

Bibliographic Details
Main Authors: Jessica L Binder, Praveen Chander, Vojo Deretic, Jason P Weick, Kiran Bhaskar
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0230026
id doaj-7cd30d21b32447aea19b7e30d252aaf8
record_format Article
spelling doaj-7cd30d21b32447aea19b7e30d252aaf82021-03-04T12:57:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01153e023002610.1371/journal.pone.0230026Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.Jessica L BinderPraveen ChanderVojo DereticJason P WeickKiran BhaskarPathological accumulation of microtubule associated protein tau in neurons is a major neuropathological hallmark of Alzheimer's disease (AD) and related tauopathies. Several attempts have been made to promote clearance of pathological tau (p-Tau) from neurons. Transcription factor EB (TFEB) has shown to clear p-Tau from neurons via autophagy. However, sustained TFEB activation and autophagy can create burden on cellular bioenergetics and can be deleterious. Here, we modified previously described two-plasmid systems of Light Activated Protein (LAP) from bacterial transcription factor-EL222 and Light Responsive Element (LRE) to encode TFEB. Upon blue-light (465 nm) illumination, the conformation changes in LAP induced LRE-driven expression of TFEB, its nuclear entry, TFEB-mediated expression of autophagy-lysosomal genes and clearance of p-Tau from neuronal cells and AD patient-derived human iPSC-neurons. Turning the blue-light off reversed the expression of TFEB-target genes and attenuated p-Tau clearance. Together, these results suggest that optically regulated TFEB expression unlocks the potential of opto-therapeutics to treat AD and other dementias.https://doi.org/10.1371/journal.pone.0230026
collection DOAJ
language English
format Article
sources DOAJ
author Jessica L Binder
Praveen Chander
Vojo Deretic
Jason P Weick
Kiran Bhaskar
spellingShingle Jessica L Binder
Praveen Chander
Vojo Deretic
Jason P Weick
Kiran Bhaskar
Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.
PLoS ONE
author_facet Jessica L Binder
Praveen Chander
Vojo Deretic
Jason P Weick
Kiran Bhaskar
author_sort Jessica L Binder
title Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.
title_short Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.
title_full Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.
title_fullStr Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.
title_full_unstemmed Optical induction of autophagy via Transcription factor EB (TFEB) reduces pathological tau in neurons.
title_sort optical induction of autophagy via transcription factor eb (tfeb) reduces pathological tau in neurons.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description Pathological accumulation of microtubule associated protein tau in neurons is a major neuropathological hallmark of Alzheimer's disease (AD) and related tauopathies. Several attempts have been made to promote clearance of pathological tau (p-Tau) from neurons. Transcription factor EB (TFEB) has shown to clear p-Tau from neurons via autophagy. However, sustained TFEB activation and autophagy can create burden on cellular bioenergetics and can be deleterious. Here, we modified previously described two-plasmid systems of Light Activated Protein (LAP) from bacterial transcription factor-EL222 and Light Responsive Element (LRE) to encode TFEB. Upon blue-light (465 nm) illumination, the conformation changes in LAP induced LRE-driven expression of TFEB, its nuclear entry, TFEB-mediated expression of autophagy-lysosomal genes and clearance of p-Tau from neuronal cells and AD patient-derived human iPSC-neurons. Turning the blue-light off reversed the expression of TFEB-target genes and attenuated p-Tau clearance. Together, these results suggest that optically regulated TFEB expression unlocks the potential of opto-therapeutics to treat AD and other dementias.
url https://doi.org/10.1371/journal.pone.0230026
work_keys_str_mv AT jessicalbinder opticalinductionofautophagyviatranscriptionfactorebtfebreducespathologicaltauinneurons
AT praveenchander opticalinductionofautophagyviatranscriptionfactorebtfebreducespathologicaltauinneurons
AT vojoderetic opticalinductionofautophagyviatranscriptionfactorebtfebreducespathologicaltauinneurons
AT jasonpweick opticalinductionofautophagyviatranscriptionfactorebtfebreducespathologicaltauinneurons
AT kiranbhaskar opticalinductionofautophagyviatranscriptionfactorebtfebreducespathologicaltauinneurons
_version_ 1714800965956141056